{"id": "c0000001", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery difficulties in the newborn.", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000001", "n000002", "n000003"]}
{"id": "c0000002", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This insulin resistance is a natural part of a healthy pregnancy and is induced by placental hormones to ensure the fetus receives the necessary nourishment for proper growth and development.", "edge_types": ["INDUCES_RESISTANCE"], "confidence": 0.6210482763808288, "edge_evidence": {"INDUCES_RESISTANCE": 2}, "node_ids": ["n000004", "n000005", "n000006"]}
{"id": "c0000003", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "However, when maternal beta cells cannot adapt to the metabolic changes associated with pregnancy, gestational diabetes mellitus (GDM) results in hyperglycemia.", "edge_types": ["FAILURE_LEADS_TO_GDM"], "confidence": 0.7901782181388181, "edge_evidence": {"FAILURE_LEADS_TO_GDM": 4}, "node_ids": ["n000007", "n000001", "n000008", "n000009"]}
{"id": "c0000004", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may also deteriorate as time passes [16].", "edge_types": ["BETA_CELL_LIMITATION", "PERSISTENT_INSULIN_RESISTANCE"], "confidence": 0.772415320751363, "edge_evidence": {"BETA_CELL_LIMITATION": 2, "PERSISTENT_INSULIN_RESISTANCE": 3}, "node_ids": ["n000001", "n000004", "n000009"]}
{"id": "c0000005", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, are risk factors for the relatively quick onset of diabetes mellitus following childbirth.", "edge_types": ["REQUIRES_COMPENSATION"], "confidence": 0.6210482763808288, "edge_evidence": {"REQUIRES_COMPENSATION": 2}, "node_ids": ["n000004", "n000009"]}
{"id": "c0000006", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "edge_types": ["BETA_CELL_LIMITATION", "REQUIRES_COMPENSATION"], "confidence": 0.691256474184962, "edge_evidence": {"BETA_CELL_LIMITATION": 2, "REQUIRES_COMPENSATION": 2}, "node_ids": ["n000004", "n000009"]}
{"id": "c0000007", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The modified Pedersen's theory, therefore, states that regardless of glucose stimulation, greater fetal insulin production results from extra glucose transported across the placenta in high and uncontrolled maternal glucose levels [22].", "edge_types": ["CROSSES_PLACENTA", "STIMULATES_INSULIN"], "confidence": 0.772415320751363, "edge_evidence": {"CROSSES_PLACENTA": 3, "STIMULATES_INSULIN": 2}, "node_ids": ["n000005"]}
{"id": "c0000008", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Xiang et al. [18] 2010 Weight gain is the main predictor related to deteriorating beta cell compensation for insulin resistance in Hispanic women at high risk of type 2 diabetes, according to these findings.", "edge_types": ["REQUIRES_COMPENSATION"], "confidence": 0.7130001627522815, "edge_evidence": {"REQUIRES_COMPENSATION": 3}, "node_ids": ["n000002", "n000004", "n000009"]}
{"id": "c0000009", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Post-partum evaluation of glucose tolerance and appropriate counselling in women with GDM may help decrease the high risk of subsequent type 2 diabetes in the longterm.", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000001", "n000002"]}
{"id": "c0000010", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses through the third trimester to the level that approximates the insulin resistance seen in individuals with type 2 diabetes mellitus.", "edge_types": ["INDUCES_RESISTANCE"], "confidence": 0.6210482763808288, "edge_evidence": {"INDUCES_RESISTANCE": 2}, "node_ids": ["n000002", "n000004"]}
{"id": "c0000011", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The second change is the compensatory increase in insulin secretion by the pancreatic beta-cells to overcome the insulin resistance of pregnancy.", "edge_types": ["INDUCES_RESISTANCE", "REQUIRES_COMPENSATION"], "confidence": 0.691256474184962, "edge_evidence": {"INDUCES_RESISTANCE": 2, "REQUIRES_COMPENSATION": 2}, "node_ids": ["n000004", "n000010"]}
{"id": "c0000012", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Risks to the Foetus & the Neonate (Tables 1 & 2): if the mother has hyperglycaemia, the foetus will be exposed to either sustained hyperglycaemia or intermittent pulses of hyperglycaemia; both situations prematurely stimulate foetal insulin secretion.", "edge_types": ["STIMULATES_INSULIN"], "confidence": 0.6210482763808288, "edge_evidence": {"STIMULATES_INSULIN": 2}, "node_ids": null}
{"id": "c0000013", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Neonatal complications in diabetic pregnancy Traumatic delivery Pulmonary surfactant deficiency Hypoglycaemia Polycythaemia Hypocalcaemia Hypomagnesaemia Hyperbilirubinaemia Foetal hyperinsulinaemia may cause increased foetal body fat (macrosomia) resulting in difficult delivery.", "edge_types": ["STIMULATES_INSULIN", "PROMOTES_GROWTH"], "confidence": 0.772415320751363, "edge_evidence": {"STIMULATES_INSULIN": 3, "PROMOTES_GROWTH": 3}, "node_ids": ["n000003"]}
{"id": "c0000014", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "edge_types": ["MONITORING_TARGETS"], "confidence": 0.7130001627522815, "edge_evidence": {"MONITORING_TARGETS": 3}, "node_ids": ["n000011"]}
{"id": "c0000015", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "edge_types": ["MONITORING_TARGETS"], "confidence": 0.7083223432721182, "edge_evidence": {"MONITORING_TARGETS": 3}, "node_ids": ["n000011", "n000012"]}
{"id": "c0000016", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "edge_types": ["INDUCES_RESISTANCE"], "confidence": 0.616755616675938, "edge_evidence": {"INDUCES_RESISTANCE": 2}, "node_ids": ["n000001", "n000004"]}
{"id": "c0000017", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000001", "n000002", "n000013"]}
{"id": "c0000018", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria. (Table 7) Women with a history of GDM should be screened for GDM during any future pregnancy.", "edge_types": ["POSTPARTUM_OGTT"], "confidence": 0.7101988493593304, "edge_evidence": {"POSTPARTUM_OGTT": 3}, "node_ids": ["n000001", "n000014", "n000013"]}
{"id": "c0000019", "doc": "Gestational_diabetes_update_screening_diagnosis_and_maternal_management.txt", "text": "Gestational diabetes is a significant risk factor for the development of type 2 diabetes and cardiovascular disease, and long-term surveillance is indicated.", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000007", "n000002"]}
{"id": "c0000020", "doc": "Gestational_diabetes_update_screening_diagnosis_and_maternal_management.txt", "text": "As gestational diabetes is also associated with an increased risk of cardiovascular disease (twofold), cardiovascular disease risk factors should be regularly assessed and managed.38 Optimisation of lifestyle factors remains key in prevention of progression to type 2 diabetes.", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000007", "n000002"]}
{"id": "c0000021", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Glycated hemoglobin (HbA1c) (<6.5%) optimization and supplementation with folic acid are critically required prior to conception in all women with previously diagnosed diabetes.", "edge_types": ["MONITORING_TARGETS"], "confidence": 0.7130001627522815, "edge_evidence": {"MONITORING_TARGETS": 3}, "node_ids": ["n000011"]}
{"id": "c0000022", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "edge_types": ["POSTPARTUM_OGTT"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_OGTT": 3}, "node_ids": ["n000015", "n000014"]}
{"id": "c0000023", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "edge_types": ["MONITORING_TARGETS"], "confidence": 0.7130001627522815, "edge_evidence": {"MONITORING_TARGETS": 3}, "node_ids": ["n000011"]}
{"id": "c0000024", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Further, it is also emphasized in some recommendations that children born to women with GDM have long-term risks of obesity and later development of T2DM, thus requiring follow-up care for many years after delivery [13].", "edge_types": ["POSTPARTUM_T2DM_RISK"], "confidence": 0.7130001627522815, "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "node_ids": ["n000001", "n000016"]}
{"id": "c0000025", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The mother's hyperglycemic state causes fetal abnormalities of pregnancy; glucose is transferred from the mother to the fetus through the placenta, resulting in macrosomia, intrauterine growth restriction, congenital anomalies, preterm birth, and neonatal hypoglycemia in the newly born infants [23].", "edge_types": ["CROSSES_PLACENTA"], "confidence": 0.7120681904038988, "edge_evidence": {"CROSSES_PLACENTA": 3}, "node_ids": ["n000005", "n000003"]}
{"id": "c0000026", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It occurs as a result of hyperglycemia in the maternal circulation, which crosses the placenta and leads to fetal hyperinsulinemia.", "edge_types": ["STIMULATES_INSULIN"], "confidence": 0.7130001627522815, "edge_evidence": {"STIMULATES_INSULIN": 3}, "node_ids": ["n000008", "n000017", "n000005"]}
{"id": "c0000027", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Furthermore, macrosomic neonates are prone to neonatal hypoglycemia (25% incidence rate) since the intrauterine hyperglycemic environment leads their pancreas to continue releasing excess insulin, and their blood glucose can fall sharply once glucose transfer from the placenta is stopped after birth.", "edge_types": ["CROSSES_PLACENTA"], "confidence": 0.7120681904038988, "edge_evidence": {"CROSSES_PLACENTA": 3}, "node_ids": ["n000005"]}
{"id": "c0000028", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It has been suggested that the following heightened risk is due to the intrauterine environment, with fetal overinsulin production and abnormal growth patterns setting the stage for later metabolic malfunction [32].", "edge_types": ["STIMULATES_INSULIN", "PROMOTES_GROWTH"], "confidence": 0.772415320751363, "edge_evidence": {"STIMULATES_INSULIN": 2, "PROMOTES_GROWTH": 3}, "node_ids": null}
{"id": "c0000029", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "edge_types": ["POSTPARTUM_OGTT"], "confidence": 0.7101988493593304, "edge_evidence": {"POSTPARTUM_OGTT": 3}, "node_ids": ["n000016", "n000015", "n000013"]}
